News tagged with 'Irritable Bowel Syndrome Drugs'

Government watchdog Public Citizen criticized the U.S. Food and Drug Administration (FDA) last week for approving the reintroduction of the gastrointestinal drug Lotronex. In a press release issued last Friday, the interest group warned consumers that the new FDA restrictions are inadequate. According to Public Citiz

A government panel of scientists and doctors assembled by the U.S. Food and Drug Administration (FDA) recommended yesterday the return of the gastrointestinal drug Lotronex. Since the drug was pulled from the market in November 2000, GlaxoSmithKline, Lotronex's maker, and the FDA have received thousands of letters fro

Pharmaceutical maker GlaxoSmithKline is seeking approval from the U.S. Food and Drug Administration (FDA) to reintroduce the irritable bowel syndrome (IBS) drug Lotronex. The gastrointestinal drug was recalled in November 2000 after FDA investigators discovered that the use of Lotronex could result in ischemic colitis

The Food & Drug Administration (FDA) considers irritable bowel syndrome to be a "serious" condition. As such, any drug proposed to treat irritable bowel syndrome may undergo an expedited review by the FDA. It is this faster than normal review process that critics say caused FDA investigators to dismiss troubling warn

For many women suffering from Irritable Bowel Syndrome (IBS), the approval of Lotronex in February 2000 was a blessing. However, the drug was pulled from the market less than six months after it was approved. This was because many patients using Lotronex were diagnosed with ischemic colitis and severe constipation.

It took less than 12 months for a promising new drug designed to fight irritable bowel syndrome to be removed from the market due to safety concerns. Lotronex, approved by the Food & Drug Administration (FDA) in February 2000, was pulled from the market today due to an alarming number of serious side effects, includin

Despite the fact that GlaxoSmithKline was forced to remove Lotronex from the market due to serious and possibly deadly side effects, many consumers who used the product have written the Food and Drug Administration asking that Lotronex be brought back. Lotronex, a medicine prescribed to treat Irritable Bowel Syndrome,